Publications by authors named "J Vandervoort"

Background: The purpose of this paper is to provide a preliminary evaluation of treatment outcomes, retention and client satisfaction following a 12-week combined cognitive behavioural therapy (CBT) and motivational enhancement therapy (MET) group treatment for cannabis use disorder (CUD) delivered in an outpatient setting. Implementation of the program is also described.

Methods: A retrospective observational cohort study was conducted using data collected from medical records and self-report assessments.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the effects of switching patients with inflammatory bowel disease from the original adalimumab drug to its biosimilar, SB5, particularly focusing on trough levels, effectiveness, and patient satisfaction.* -
  • Conducted on 110 patients, it found that after the switch, trough levels stayed in the therapeutic range, with an 84.6% acceptance rate and 74.5% drug persistence after 12 months, demonstrating good patient compliance.* -
  • Results indicated no significant deterioration in disease activity and a high level of patient satisfaction, though some patients experienced injection site pain, which was generally mild and limited to the initial 30 minutes post-injection.*
View Article and Find Full Text PDF

Background: Impact of antithrombotics on the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening remains unclear.

Methods: Patients undergoing colonoscopy for positive FIT in 2015 were assessed at 3 Belgian centers. Significant findings were advanced polyps (AP) (sessile serrated, tubular or villous adenomas >1cm or high-grade dysplasia) and CRC.

View Article and Find Full Text PDF

The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. 1 : ESGE recommends colonic stenting to be reserved for patients with clinical symptoms and radiological signs of malignant large-bowel obstruction, without signs of perforation. ESGE does not recommend prophylactic stent placement.

View Article and Find Full Text PDF

Background: The natural history of ulcerative colitis (UC) is unpredictable. Factors associated with the need for different types of step-up therapy in UC patients failing on 5-aminosalicylic acid (5-ASA) or corticosteroids are understudied.

Aims: Describe step-up therapy in patients with UC the first year after failing on 5-ASA or corticosteroids.

View Article and Find Full Text PDF